Vasculogenic cytokines in wound healing

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wong, Victor W ^a   Crawford, Jeffrey D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLATELET DERIVED GROWTH FACTOR; S1P PROTEIN; STROMAL CELL DERIVED FACTOR 1; STRUCTURAL PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOGENIC CYTOKINE; VASCULOTROPIN;

AGING; ANGIOGENESIS; BONE MARROW DERIVED CIRCULATING ENDOTHELIAL PROGENITOR CELL; CELL MIGRATION; CELL MOTILITY; CELL THERAPY; CHRONIC WOUND; EMBRYO DEVELOPMENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEALTH CARE; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SPROUTING; STEM CELL; TISSUE REGENERATION; WOUND HEALING; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; INJURY; METABOLISM; SKIN;

BONE MARROW CELLS; CELL DIFFERENTIATION; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; STEM CELLS; WOUND HEALING;

EID: 84875461657     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/190486     Document Type: Review

References (137)

1. Kahn R., Robertson R. M., Smith R., Eddy D., The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008 118 5 576 585 2-s2.0-49649102993 10.1161/CIRCULATIONAHA.108.190186
2. Sen C. K., Gordillo G. M., Roy S., Kirsner R., Lambert L., Hunt T. K., Gottrup F., Gurtner G. C., Longaker M. T., Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair and Regeneration 2009 17 6 763 771 2-s2.0-70350680485 10.1111/j.1524-475X.2009. 00543.x
3. Wu S. C., Driver V. R., Wrobel J. S., Armstrong D. G., Foot ulcers in the diabetic patient, prevention and treatment. Vascular Health and Risk Management 2007 3 1 65 76 2-s2.0-34249860326 (Pubitemid 46860717)
4. Stockl K., Vanderplas A., Tafesse E., Chang E., Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care 2004 27 9 2129 2134 2-s2.0-4444378325 10.2337/diacare.27.9.2129 (Pubitemid 39167174)
5. Brown J. B., Pedula K. L., Bakst A. W., The progressive cost of complications in type 2 diabetes mellitus. Archives of Internal Medicine 1999 159 16 1873 1880 2-s2.0-0033552080 10.1001/archinte.159.16.1873 (Pubitemid 29424707)
6. Carral F., Aguilar M., Olveira G., Mangas A., Doménech I., Torres I., Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. Journal of Diabetes and its Complications 2003 17 6 331 336 2-s2.0-0142138130 10.1016/S1056-8727(02)00219-2 (Pubitemid 37315942)
7. Yancopoulos G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., Holash J., Vascular-specific growth factors and blood vessel formation. Nature 2000 407 6801 242 248 2-s2.0-0034648793 10.1038/35025215
8. Bauer S. M., Bauer R. J., Velazquez O. C., Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vascular and Endovascular Surgery 2005 39 4 293 306 2-s2.0-23044438985 10.1177/153857440503900401 (Pubitemid 41061696)
9. Ferguson J. E., Kelley R. W., Patterson C., Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 11 2246 2254 2-s2.0-27644435456 10.1161/01.ATV. 0000183609.55154.44 (Pubitemid 41552639)
10. Ferrara N., Kerbel R. S., Angiogenesis as a therapeutic target. Nature 2005 438 7070 967 974 2-s2.0-30744449235 10.1038/nature04483 (Pubitemid 43093963)
11. Ding Y. T., Kumar S., Yu D. C., The role of endothelial progenitor cells in tumour vasculogenesis. Pathobiology 2008 75 5 265 273 2-s2.0-54249104115 10.1159/000151706
12. Swift M. R., Weinstein B. M., Arterial-venous specification during development. Circulation Research 2009 104 5 576 588 2-s2.0-63649138023 10.1161/CIRCRESAHA.108.188805
13. Folkman J., Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine 1971 285 21 1182 1186 2-s2.0-0015231516
14. Tepper O. M., Capla J. M., Galiano R. D., Ceradini D. J., Callaghan M. J., Kleinman M. E., Gurtner G. C., Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005 105 3 1068 1077 2-s2.0-12844252393 10.1182/blood-2004-03-1051 (Pubitemid 40170877)
15. Semenza G. L., Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. Journal of Cellular Biochemistry 2007 102 4 840 847 2-s2.0-35648932996 10.1002/jcb.21523 (Pubitemid 350036924)
16. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 5302 964 967 2-s2.0-0031019745 10.1126/science.275.5302.964 (Pubitemid 27087709)
17. Carmeliet P., Manipulating angiogenesis in medicine. Journal of Internal Medicine 2004 255 5 538 561 2-s2.0-2042535361 10.1111/j.1365-2796.2003.01297.x (Pubitemid 38534868)
18. Asahara T., Kawamoto A., Masuda H., Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011 29 1650 1655
19. Sieveking D. P., Buckle A., Celermajer D. S., Ng M. K. C., Strikingly different angiogenic properties of endothelial progenitor cell subpopulations. Insights from a novel human angiogenesis assay. Journal of the American College of Cardiology 2008 51 6 660 668 2-s2.0-38749090588 10.1016/j.jacc.2007.09.059 (Pubitemid 351186872)
20. Medina R. J., O'Neill C. L., Sweeney M., Guduric-Fuchs J., Gardiner T. A., Simpson D. A., Stitt A. W., Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Medical Genomics 2010 3, article no. 18 2-s2.0-77952065242 10.1186/1755-8794-3-18
21. Timmermans F., Plum J., Yöder M. C., Ingram D. A., Vandekerckhove B., Case J., Endothelial progenitor cells: identity defined? Journal of Cellular and Molecular Medicine 2009 13 1 87 102 2-s2.0-58649108952 10.1111/j.1582-4934. 2008.00598.x
22. Lamping K., Endothelial progenitor cells: sowing the seeds for vascular repair. Circulation Research 2007 100 9 1243 1245 2-s2.0-34248396011 10.1161/01.RES.0000268193.46418.d1 (Pubitemid 46742914)
23. Zampetaki A., Kirton J. P., Xu Q., Vascular repair by endothelial progenitor cells. Cardiovascular Research 2008 78 3 413 421 2-s2.0-44449109955 10.1093/cvr/cvn081 (Pubitemid 351769775)
24. Urbich C., Heeschen C., Aicher A., Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nature Medicine 2005 11 206 213 (Pubitemid 40321357)
25. Cheng X. W., Kuzuya M., Nakamura K., Maeda K., Tsuzuki M., Kim W., Sasaki T., Liu Z., Inoue N., Kondo T., Jin H., Numaguchi Y., Okumura K., Yokota M., Iguchi A., Murohara T., Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circulation Research 2007 100 6 904 913 2-s2.0-34147120072 10.1161/01.RES.0000260801.12916. b5 (Pubitemid 46555696)
26. Hamed S., Brenner B., Aharon A., Daoud D., Roguin A., Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovascular Diabetology 2009 8, article no. 56 2-s2.0-71149112994 10.1186/1475-2840-8-56
27. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J. M., Asahara T., Losordo D. W., Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003 108 25 3115 3121 2-s2.0-0346157997 10.1161/01.CIR.0000106906. 56972.83 (Pubitemid 38031801)
28. Crisan M., Yap S., Casteilla L., Chen C. W., Corselli M., Park T. S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P. N., Traas J., Schugar R., Deasy B. M., Badylak S., Buhring H. J., Giacobino J. P., Lazzari L., Huard J., Péault B., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008 3 3 301 313 2-s2.0-50849139576 10.1016/j.stem.2008.07.003
29. Gerhardt H., Betsholtz C., Endothelial-pericyte interactions in angiogenesis. Cell and Tissue Research 2003 314 1 15 23 2-s2.0-0242405617 10.1007/s00441-003-0745-x (Pubitemid 37409909)
30. Loffredo F., Lee R. T., Therapeutic vasculogenesis: it takes two. Circulation Research 2008 103 2 128 130 2-s2.0-48849090910 10.1161/CIRCRESAHA. 108.180604
31. Bauer S. M., Bauer R. J., Liu Z. J., Chen H., Goldstein L., Velazquez O. C., Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. Journal of Vascular Surgery 2005 41 4 699 707 2-s2.0-18344391843 10.1016/j.jvs.2005.01.015 (Pubitemid 40637671)
32. Rafii D. C., Psaila B., Butler J., Jin D. K., Lyden D., Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 217 222 2-s2.0-38549154715 10.1161/ATVBAHA.107.151159 (Pubitemid 351161192)
33. Coultas L., Chawengsaksophak K., Rossant J., Endothelial cells and VEGF in vascular development. Nature 2005 438 7070 937 945 2-s2.0-30744432619 10.1038/nature04479 (Pubitemid 43093959)
34. Roskoski R., VEGF receptor protein-tyrosine kinases: structure and regulation. Biochemical and Biophysical Research Communications 2008 375 3 287 291 2-s2.0-50849120002 10.1016/j.bbrc.2008.07.121
35. Nagy J. A., Dvorak A. M., Dvorak H. F., VEGF-A164/165 and PlGF: roles in angiogenesis and arteriogenesis. Trends in Cardiovascular Medicine 2003 13 5 169 175 2-s2.0-0038692867 10.1016/S1050-1738(03)00056-2 (Pubitemid 36802019)
36. Li Y., Zhang F., Nagai N., Tang Z., Zhang S., Scotney P., Lennartsson J., Zhu C., Qu Y., Fang C., Hua J., Matsuo O., Fong G. H., Ding H., Cao Y., Becker K. G., Nash A., Heldin C. H., Li X., VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. Journal of Clinical Investigation 2008 118 3 913 923 2-s2.0-40549090548 10.1172/JCI33673 (Pubitemid 351364599)
37. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J. M., VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. The EMBO Journal 1999 18 14 3964 3972 2-s2.0-0033565540 10.1093/emboj/18.14.3964 (Pubitemid 29335849)
38. Li B., Sharpe E. E., Maupin A. B., Teleron A. A., Pyle A. L., Carmeliet P., Young P. P., VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. The FASEB Journal 2006 20 9 1495 1497 2-s2.0-33746546426 10.1096/fj.05-5137fje (Pubitemid 44961985)
39. Galiano R. D., Tepper O. M., Pelo C. R., Bhatt K. A., Callaghan M., Bastidas N., Bunting S., Steinmetz H. G., Gurtner G. C., Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. American Journal of Pathology 2004 164 6 1935 1947 2-s2.0-2442717879 (Pubitemid 38669343)
40. Caiado F., Dias S., Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair 2012 5, article 4
41. Ceradini D. J., Gurtner G. C., Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends in Cardiovascular Medicine 2005 15 2 57 63 2-s2.0-18844406447 10.1016/j.tcm.2005.02.002 (Pubitemid 40693388)
42. Thangarajah H., Yao D., Chang E. I., Shi Y., Jazayeri L., Vial I. N., Galiano R. D., Du X. L., Grogan R., Galvez M. G., Januszyk M., Brownlee M., Gurtner G. C., The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proceedings of the National Academy of Sciences of the United States of America 2009 106 32 13505 13510 2-s2.0-69449108536 10.1073/pnas.0906670106
43. Hoenig M. R., Bianchi C., Sellke F. W., Hypoxia inducible factor -1 α endothelial progenitor cells, monocytes cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Current Drug Targets 2008 9 5 422 435 2-s2.0-44949206575 10.2174/138945008784221215 (Pubitemid 352025218)
44. Botusan I. R., Sunkari V. G., Savu O., Catrina A. I., Grünler J., Lindberg S., Pereira T., Ylä-Herttuala S., Poellinger L., Brismar K., Catrina S. B., Stabilization of HIF-1 α is critical to improve wound healing in diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 2008 105 49 19426 19431 2-s2.0-58049209727 10.1073/pnas.0805230105
45. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T., Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999 283 5403 845 848 2-s2.0-0033524834 10.1126/science.283.5403. 845 (Pubitemid 29072324)
46. McGrath K. E., Koniski A. D., Maltby K. M., McGann J. K., Palis J., Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Developmental Biology 1999 213 2 442 456 2-s2.0-0033568470 10.1006/dbio.1999.9405 (Pubitemid 29444352)
47. Gurtner G. C., Loh S. A., Chang E. I., Galvez M. G., Thangarajah H., El-Ftesi S., Vial I. N., Lin D. A., SDF-1 α expression during wound healing in the aged is HIF dependent. Plastic and Reconstructive Surgery 2009 123 65S 75S 2-s2.0-61749087539 10.1097/PRS.0b013e318191bdf4
48. Ceradini D. J., Kulkarni A. R., Callaghan M. J., Tepper O. M., Bastidas N., Kleinman M. E., Capla J. M., Galiano R. D., Levine J. P., Gurtner G. C., Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine 2004 10 8 858 864 2-s2.0-4043184065 10.1038/nm1075 (Pubitemid 39070860)
49. Yamaguchi J. I., Kusano K. F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D. W., Isner J. M., Asahara T., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003 107 9 1322 1328 2-s2.0-0037432293 10.1161/01.CIR.0000055313.77510.22 (Pubitemid 36314418)
50. Hiasa K. I., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004 109 20 2454 2461 2-s2.0-2542464782 10.1161/01.CIR.0000128213. 96779.61 (Pubitemid 38679567)
51. Gallagher K. A., Liu Z. J., Xiao M., Chen H., Goldstein L. J., Buerk D. G., Nedeau A., Thom S. R., Velazquez O. C., Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 α Journal of Clinical Investigation 2007 117 5 1249 1259 2-s2.0-34248213008 10.1172/JCI29710 (Pubitemid 46718413)
52. Xing D., Liu L., Marti G. P., Zhang X., Reinblatt M., Milner S. M., Harmon J. W., Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair and Regeneration 2011 19 2 205 213 2-s2.0-79952254556 10.1111/j.1524-475X.2010.00656.x
53. Lerman O. Z., Greives M. R., Singh S. P., Thanik V. D., Chang C. C., Seiser N., Brown D. J., Knobel D., Schneider R. J., Formenti S. C., Saadeh P. B., Levine J. P., Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction. Blood 2010 116 18 3669 3676 2-s2.0-78149300933 10.1182/blood-2009-03-213629
54. Holmes D. I. R., Zachary I., The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biology 2005 6 2, article no. 209 2-s2.0-14844357211 10.1186/gb-2005-6-2-209 (Pubitemid 40352680)
55. Lange S., Heger J., Euler G., Wartenberg M., Piper H. M., Sauer H., Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovascular Research 2009 81 1 159 168 2-s2.0-57749204525 10.1093/cvr/cvn258
56. Hellström M., Kalén M., Lindahl P., Abramsson A., Betsholtz C., Role of PDGF-B and PDGFR- β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999 126 14 3047 3055 2-s2.0-0032768156 (Pubitemid 29378170)
57. Lindahl P., Hellström M., Kalén M., Karlsson L., Pekny M., Pekna M., Soriano P., Betsholtz C., Paracrine PDGF-B/PDGF-R β signaling controls mesangial cell development in kidney glomeruli. Development 1998 125 17 3313 3322 2-s2.0-0031668536 (Pubitemid 28458331)
58. Ball S. G., Shuttleworth C. A., Kielty C. M., Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. Journal of Cellular and Molecular Medicine 2007 11 5 1012 1030 2-s2.0-35649026803 10.1111/j.1582-4934.2007.00120.x (Pubitemid 350037047)
59. Jin Q., Wei G., Lin Z., Sugai J. V., Lynch S. E., Ma P. X., Giannobile W. V., Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS ONE 2008 3 3 2-s2.0-45849112200 10.1371/journal.pone.0001729 e1729 (Pubitemid 351903228)
60. Magnusson P. U., Looman C., Åhgren A., Wu Y., Claesson-Welsh L., Heuchel R. L., Platelet-derived growth factor receptor- β constitutive activity promotes angiogenesis in vivo and in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 10 2142 2149 2-s2.0-35148818269 10.1161/01.ATV.0000282198.60701.94 (Pubitemid 350287242)
61. Shen J., Vil M. D., Prewett M., Damoci C., Zhang H., Li H., Jimenez X., Deevi D. S., Iacolina M., Kayas A., Bassi R., Persaud K., Rohoza-Asandi A., Balderes P., Loizos N., Ludwig D. L., Tonra J., Witte L., Zhu Z., Development of a fully human anti-PDGFR β antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody. Neoplasia 2009 11 6 594 604 2-s2.0-66449132035 10.1593/neo.09278
62. Murphy M. O., Ghosh J., Fulford P., Khwaja N., Halka A. T., Carter A., Turner N. J., Walker M. G., Expression of growth factors and growth factor receptor in non-healing and healing ischaemic ulceration. European Journal of Vascular and Endovascular Surgery 2006 31 5 516 522 2-s2.0-33645910202 10.1016/j.ejvs.2005.12.002
63. Jain R. K., Molecular regulation of vessel maturation. Nature Medicine 2003 9 6 685 693 2-s2.0-0038376002 10.1038/nm0603-685 (Pubitemid 36749217)
64. Robson M. C., Hill D. P., Smith P. D., Wang X., Meyer-Siegler K., Ko F., VandeBerg J. S., Payne W. G., Ochs D., Robson L. E., Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Annals of Surgery 2000 231 4 600 611 2-s2.0-0034031419 10.1097/00000658-200004000-00020 (Pubitemid 30185868)
65. Thisse B., Thisse C., Functions and regulations of fibroblast growth factor signaling during embryonic development. Developmental Biology 2005 287 2 390 402 2-s2.0-27744534898 10.1016/j.ydbio.2005.09.011 (Pubitemid 41636772)
66. Murakami M., Simons M., Fibroblast growth factor regulation of neovascularization. Current Opinion in Hematology 2008 15 3 215 220 2-s2.0-41949092558 10.1097/MOH.0b013e3282f97d98 (Pubitemid 351507574)
67. Detillieux K. A., Sheikh F., Kardami E., Cattini P. A., Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovascular Research 2003 57 1 8 19 2-s2.0-0037216633 10.1016/S0008-6363(02)00708-3 (Pubitemid 36009431)
68. Moya M. L., Lucas S., Francis-Sedlak M., Liu X., Garfinkel M. R., Huang J. J., Cheng M. H., Opara E. C., Brey E. M., Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvascular Research 2009 78 2 142 147 2-s2.0-68349155795 10.1016/j.mvr.2009.06.006
69. Moya M. L., Cheng M. H., Huang J. J., Francis-Sedlak M. E., Kao S. W., Opara E. C., Brey E. M., The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials 2010 31 10 2816 2826 2-s2.0-75149125990 10.1016/j.biomaterials.2009.12.053
70. Layman H., Sacasa M., Murphy A. E., Murphy A. M., Pham S. M., Andreopoulos F. M., Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. Acta Biomaterialia 2009 5 1 230 239 2-s2.0-56349147736 10.1016/j.actbio.2008.07.024
71. Burger P. E., Coetzee S., McKeehan W. L., Kan M., Cook P., Fan Y., Suda T., Hebbel R. P., Novitzky N., Muller W. A., Lynette Wilson E., Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 2002 100 10 3527 3535 2-s2.0-0037111547 10.1182/blood.V100.10.3527 (Pubitemid 35303920)
72. Takahashi M., Okubo N., Chosa N., Fibroblast growth factor-1-induced ERK1/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells. International Journal of Molecular Medicine 2012 29 357 364
73. Dell'Era P., Belleri M., Stabile H., Massardi M. L., Ribatti D., Presta M., Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. Oncogene 2001 20 21 2655 2663 2-s2.0-0035837317 10.1038/sj.onc.1204368 (Pubitemid 32525296)
74. Gualandris A., Rusnati M., Belleri M., Nelli E. E., Bastaki M., Molinari-Tosatti M. P., Bonardi F., Parolini S., Albini A., Morbidelli L., Ziche M., Corallini A., Possati L., Vacca A., Ribatti D., Presta M., Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth and Differentiation 1996 7 2 147 160 2-s2.0-9044228402 (Pubitemid 26049823)
75. Asai J., Takenaka H., Ii M., Topical application of ex vivo expanded endothelial progenitor cells promotes vascularisation and wound healing in diabetic mice. International Wound Journal 2012 10.1111/j.1742-481X.2012.01010.x
76. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J. M., Asahara T., Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine 1999 5 4 434 438 2-s2.0-0032945433 10.1038/7434 (Pubitemid 29180584)
77. Mann A., Breuhahn K., Schirmacher P., Blessing M., Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. Journal of Investigative Dermatology 2001 117 6 1382 1390 2-s2.0-0035677890 10.1046/j.0022-202x.2001.01600.x (Pubitemid 34032763)
78. Hu X., Sun H., Han C., Wang X., Yu W., Topically applied rhGM-CSF for the wound healing: a systematic review. Burns 2011 37 5 728 740 2-s2.0-79960383892 10.1016/j.burns.2010.08.016
79. Hercus T. R., Thomas D., Guthridge M. A., Ekert P. G., King-Scott J., Parker M. W., Lopez A. F., The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 2009 114 7 1289 1298 2-s2.0-70349336496 10.1182/blood-2008-12-164004
80. Eubank T. D., Roberts R., Galloway M., Wang Y., Cohn D. E., Marsh C. B., GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004 21 6 831 842 2-s2.0-10344251488 10.1016/j.immuni.2004.10.011 (Pubitemid 39626673)
81. Grote K., Schuett H., Salguero G., Grothusen C., Jagielska J., Drexler H., Mühlradt P. F., Schieffer B., Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration. Blood 2010 115 12 2543 2552 2-s2.0-77950554962 10.1182/blood-2009-05-224402
82. Zhao W., Yang X. H., PI3K-dependent ERK is involved in GM-CSF-mediated activation of progenitor cells in a neovasculari sation model. South African Journal of Science 2010 106 5-6 2-s2.0-77953556620 10.4102/sajs.v106i5/6.214
83. Kovacic J. C., Muller D. W. M., Graham R. M., Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. Journal of Molecular and Cellular Cardiology 2007 42 1 19 33 2-s2.0-33845668020 10.1016/j.yjmcc.2006. 10.001 (Pubitemid 44958629)
84. Shen R., Ye Y., Chen L., Yan Q., Barsky S. H., Gao J. X., Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 2008 3 2 2-s2.0-45749143564 10.1371/journal.pone.0001652 e1652 (Pubitemid 351865455)
85. Estrada R., Zeng Q., Lu H., Sarojini H., Lee J. F., Mathis S. P., Sanchez T., Wang E., Kontos C. D., Lin C. Y., Hla T., Haribabu B., Lee M. J., Up-regulating sphingosine 1-phosphate receptor-2 signaling impairs chemotactic, wound-healing, and morphogenetic responses in senescent endothelial cells. The Journal of Biological Chemistry 2008 283 44 30363 30375 2-s2.0-57649194902 10.1074/jbc.M804392200
86. Vogler R., Sauer B., Kim D. S., Schäfer-Korting M., Kleuser B., Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. Journal of Investigative Dermatology 2003 120 4 693 700 2-s2.0-0037378439 10.1046/j.1523-1747.2003.12096.x (Pubitemid 36344015)
87. Kawanabe T., Kawakami T., Yatomi Y., Shimada S., Soma Y., Sphingosine 1-phosphate accelerates wound healing in diabetic mice. Journal of Dermatological Science 2007 48 1 53 60 2-s2.0-34548008143 10.1016/j.jdermsci. 2007.06.002 (Pubitemid 47284808)
88. Hisano Y., Kobayashi N., Yamaguchi A., Nishi T., Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PloS One 2012 7 e38941
89. Givens C., Tzima E., S1P1 bridges mechanotransduction and angiogenesis during vascular development. Developmental Cell 2012 23 451 452
90. Tobia C., Chiodelli P., Nicoli S., Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 e104 e116
91. Argraves K. M., Wilkerson B. A., Argraves W. S., Fleming P. A., Obeid L. M., Drake C. J., Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. The Journal of Biological Chemistry 2004 279 48 50580 50590 2-s2.0-9644278040 10.1074/jbc.M404432200 (Pubitemid 39577875)
92. Liu Y., Wada R., Yamashita T., Mi Y., Deng C. X., Hobson J. P., Rosenfeldt H. M., Nava V. E., Chae S. S., Lee M. J., Liu C. H., Hla T., Spiegel S., Proia R. L., Edg-1, the G protein-coupled receptor for sphingosine-1- phosphate, is essential for vascular maturation. Journal of Clinical Investigation 2000 106 8 951 961 2-s2.0-0033783522
93. Rosenfeldt H. M., Hobson J. P., Milstien S., Spiegel S., The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. Biochemical Society Transactions 2001 29 6 836 839 2-s2.0-0035206388 10.1042/0300-5127:0290836 (Pubitemid 33131790)
94. Manuel J. A., Gawronska-Kozak B., Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. Matrix Biology 2006 25 8 505 514 2-s2.0-33751006970 10.1016/j.matbio.2006.07.008 (Pubitemid 44751450)
95. Liu Y., Min D., Bolton T., Nube V., Twigg S. M., Yue D. K., Mclennan S. V., Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009 32 1 117 119 2-s2.0-64549119604 10.2337/dc08-0763
96. Kyriakides T. R., Wulsin D., Skokos E. A., Fleckman P., Pirrone A., Shipley J. M., Senior R. M., Bornstein P., Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biology 2009 28 2 65 73 2-s2.0-62749193153 10.1016/j.matbio.2009.01.001
97. Masson V., Rodriguez De La Ballina L., Munaut C., Wielockx B., Jost M., Maillard C., Blacher S., Bajou K., Itoh T., Itohara S., Werb Z., Libert C., Foidart J. M., Noël A., Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. The FASEB Journal 2005 19 2 234 236 2-s2.0-19944431661 10.1096/fj.04-2140fje (Pubitemid 40189266)
98. Stenzel D., Franco C. A., Estrach S., Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Report 2011 12 1135 1143
99. Stratman A. N., Malotte K. M., Mahan R. D., Davis M. J., Davis G. E., Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009 114 24 5091 5101 2-s2.0-73949086144 10.1182/blood-2009-05-222364
100. Davis G. E., Senger D. R., Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circulation Research 2005 97 11 1093 1107 2-s2.0-33644683263 10.1161/01.RES.0000191547.64391.e3
101. Heissig B., Hattori K., Friedrich M., Rafii S., Werb Z., Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Current Opinion in Hematology 2003 10 2 136 141 2-s2.0-0037370649 10.1097/00062752-200303000-00007 (Pubitemid 36207969)
102. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N. R., Crystal R. G., Besmer P., Lyden D., Moore M. A. S., Werb Z., Rafii S., Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 2002 109 5 625 637 2-s2.0-18444389451 10.1016/S0092-8674(02)00754-7 (Pubitemid 34628725)
103. Bergers G., Brekken R., McMahon G., Vu T. H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D., Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology 2000 2 10 737 744 2-s2.0-0000391746 10.1038/35036374
104. Yu Q., Stamenkovic I., Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF- β and promotes tumor invasion and angiogenesis. Genes and Development 2000 14 2 163 176 2-s2.0-0034650486 (Pubitemid 30070982)
105. Ahn G. O., Brown J. M., Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008 13 3 193 205 2-s2.0-39849100541 10.1016/j.ccr.2007.11.032 (Pubitemid 351318369)
106. Huang P. H., Chen Y. H., Wang C. H., Chen J. S., Tsai H. Y., Lin F. Y., Lo W. Y., Wu T. C., Sata M., Chen J. W., Lin S. J., Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1179 1184 2-s2.0-68149099660 10.1161/ATVBAHA.109. 189175
107. Szmitko P. E., Fedak P. W. M., Weisel R. D., Stewart D. J., Kutryk M. J. B., Verma S., Endothelial progenitor cells: new hope for a broken heart. Circulation 2003 107 24 3093 3100 2-s2.0-0037805771 10.1161/01.CIR.0000074242. 66719.4A (Pubitemid 36758985)
108. Van Hinsbergh V. W. M., Engelse M. A., Quax P. H. A., Pericellular proteases in angiogenesis and vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 4 716 728 2-s2.0-33646695668 10.1161/01.ATV.0000209518. 58252.17 (Pubitemid 43732143)
109. Van Hinsbergh V. W. M., Koolwijk P., Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovascular Research 2008 78 2 203 212 2-s2.0-42349114587 10.1093/cvr/cvm102 (Pubitemid 351556093)
110. Rundhaug J. E., Matrix metalloproteinases and angiogenesis. Journal of Cellular and Molecular Medicine 2005 9 2 267 285 2-s2.0-24044459285
111. Kitisin K., Saha T., Blake T., Golestaneh N., Deng M., Kim C., Tang Y., Shetty K., Mishra B., Mishra L., Tgf-Beta signaling in development. Science's STKE 2007 2007 399 cm1 2-s2.0-35148883003 10.1126/stke.3992007cm1
112. Larson B. J., Longaker M. T., Lorenz H. P., Scarless fetal wound healing: a basic science review. Plastic and Reconstructive Surgery 2010 126 4 1172 1180 2-s2.0-77958592738 10.1097/PRS.0b013e3181eae781
113. ten Dijke P., Arthur H. M., Extracellular control of TGF-beta signalling in vascular development and disease. Nature Reviews Molecular Cell Biology 2007 8 857 869 (Pubitemid 47622560)
114. Fang S., Pentinmikko N., Ilmonen M., Salven P., Dual action of TGF-beta induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis 2012 15 511 519
115. Mallet C., Vittet D., Feige J. J., Bailly S., TGF β 1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 2006 24 11 2420 2427 2-s2.0-33750565365 10.1634/stemcells.2005-0494 (Pubitemid 44674302)
116. Wang X.-J., Dong Z., Zhong X.-H., Transforming growth factor-beta1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells. Biochemical and Biophysical Research Communications 2008 365 548 554 (Pubitemid 350181688)
117. Imamura H., Ohta T., Tsunetoshi K., Doi K., Nozaki K., Takagi Y., Kikuta K. I., Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor- β 1. Atherosclerosis 2010 211 1 114 121 2-s2.0-77954253573 10.1016/j.atherosclerosis.2010.02.040
118. Fernandez L. A., Sanz-Rodriguez F., Blanco F. J., Bernabéu C., Botella L. M., Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF- β signaling pathway. Clinical Medicine and Research 2006 4 1 66 78 2-s2.0-33646089201 10.3121/cmr.4.1.66
119. Werner S., Grose R., Regulation of wound healing by growth factors and cytokines. Physiological Reviews 2003 83 3 835 870 2-s2.0-0038676258 (Pubitemid 36828927)
120. Barrientos S., Stojadinovic O., Golinko M. S., Brem H., Tomic-Canic M., Growth factors and cytokines in wound healing. Wound Repair and Regeneration 2008 16 5 585 601 2-s2.0-51349167276 10.1111/j.1524-475X.2008.00410.x
121. Fang R. C., Galiano R. D., A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics 2008 2 1 12
122. Papanas N., Maltezos E., Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clinical Interventions in Aging 2008 3 2 233 240 2-s2.0-47849085516 (Pubitemid 352037863)
123. Gough A., Clapperton M., Rolando N., Foster A. V. M., Philpott-Howard J., Edmonds M. E., Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. The Lancet 1997 350 9081 855 859
124. De Lalla F., Pellizzer G., Strazzabosco M., Martini Z., Du Jardin G., Lora L., Fabris P., Benedetti P., Erle G., Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrobial Agents and Chemotherapy 2001 45 4 1094 1098 2-s2.0-0035080974 10.1128/AAC.45.4.1094-1098. 2001 (Pubitemid 32230987)
125. Marques Da Costa R., Aniceto C., Miguel Jesus F., Mendes M., Quick healing of leg ulcers after molgramostim. The Lancet 1994 344 8920 481 482 2-s2.0-0027941149 (Pubitemid 24248277)
126. Pojda Z., Struzyna J., Treatment of non-healing ulcers with rhGM-CSF and skin grafts. The Lancet 1994 343 8905 1100 2-s2.0-0028286828 (Pubitemid 24128220)
127. Raderer M., Kornek G., Hejna M., Koperna K., Scheithauer W., Base W., Topical granulocyte-macrophage colony-stimulating factor in patients with cancer and impaired wound healing. Journal of the National Cancer Institute 1997 89 3 263 2-s2.0-18744437048 (Pubitemid 27073766)
128. Arnold F., O'Brien J., Cherry G., Granulocyte monocyte-colony stimulating factor as an agent for wound healing. A study evaluating the use of local injections of a genetically engineered growth factor in the management of wounds with a poor healing prognosis. Journal of Wound Care 1995 4 9 400 402 2-s2.0-0029391105
129. Marques Da Costa R., Jesus F. M., Aniceto C., Mendes M., Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. American Journal of Surgery 1997 173 3 165 168 2-s2.0-0342871993 10.1016/S0002-9610(97)89589-X (Pubitemid 27163841)
130. Fivenson D. P., Faria D. T., Nickoloff B. J., Poverini P. J., Kunkel S., Burdick M., Strieter R. M., Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair and Regeneration 1997 5 4 310 322 2-s2.0-0000363576 (Pubitemid 127689592)
131. Drinkwater S. L., Burnand K. G., Ding R., Smith A., Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. Journal of Vascular Surgery 2003 38 5 1106 1112 2-s2.0-0242491583 10.1016/S0741-5214(03) 01053-X (Pubitemid 37409649)
132. Hiasa K. I., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004 109 20 2454 2461 2-s2.0-2542464782 10.1161/01.CIR.0000128213. 96779.61 (Pubitemid 38679567)
133. Iwaguro H., Yamaguchi J. I., Kalka C., Murasawa S., Masuda H., Hayashi S. I., Silver M., Li T., Isner J. M., Asahara T., Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002 105 6 732 738 2-s2.0-0037065852 10.1161/hc0602.103673 (Pubitemid 34157378)
134. Rabbany S. Y., Pastore J., Yamamoto M., Miller T., Rafii S., Aras R., Penn M., Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplantation 2010 19 4 399 408 2-s2.0-77953747577 10.3727/096368909X481782
135. Henderson P. W., Singh S. P., Krijgh D. D., Yamamoto M., Rafii D. C., Sung J. J., Rafii S., Rabbany S. Y., Spector J. A., Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo. Wound Repair and Regeneration 2011 19 3 420 425 2-s2.0-79955743145 10.1111/j.1524-475X.2011.00687.x
136. Hanjaya-Putra D., Wong K. T., Hirotsu K., Khetan S., Burdick J. A., Gerecht S., Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels. Biomaterials 2012 33 6123 6131
137. Hanjaya-Putra D., Bose V., Shen Y. I., Yee J., Khetan S., Fox-Talbot K., Steenbergen C., Burdick J. A., Gerecht S., Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 2011 118 3 804 815 2-s2.0-79960674761 10.1182/blood-2010-12-327338